Wegovy is prescribed to be taken just once a week alongside a diet and exercise plan to help you lose weight
For type 2 diabetes management , NICE guideline NG28 recommends considering GLP-1 receptor agonists when: Triple therapy with metformin and two other oral medications is ineffective, not tolerated or contraindicated The patient has a body mass index (BMI) of 35 kg/m or higher (with lower thresholds for people from certain ethnic backgrounds), or lower BMI with specific clinical circumstances where weight loss would benefit other obesity-related comorbidities Insulin would have significant occupational implications GLP-1 therapy should only be continued beyond six months if there has been a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0 percentage point) and weight loss of at least 3% of initial body weight
It extends the same caution to people with a history of trauma, restrictive eating, or body image concerns, where rapid weight loss can unmask psychological vulnerabilities
It's often studied alongside GLP-1 drugs like semaglutide because the two pathways produce complementary appetite-suppressing effects
A healthcare professional may suggest periodic breaks or adjust dosages to prevent tolerance and ensure optimal results
Start your day with a glass of water before taking your semaglutide injection, and keep a water bottle visible as a reminder throughout the day